| 000 | 00999nam a2200253I 4500 | ||
|---|---|---|---|
| 999 |
_c12992 _d12992 |
||
| 001 | 7439017 | ||
| 008 | 810521s1981 mdua 00100 eng d | ||
| 010 | _a81000388 | ||
| 020 | _a0806708212 | ||
| 040 |
_aNBG _cNBG _dMXC |
||
| 100 |
_aZOLA,P. HOROVITZ _d1981 |
||
| 245 | 1 | 0 |
_aAngiotensin converting enzyme inhibitors : _bmechanisms of action and clinical implications / _cedited by Zola P. Horovitz |
| 260 | 0 |
_aBaltimore : _bUrban & Schwarzenberg, _c1981 |
|
| 300 |
_axv, 451 p. : _bill. ; _c24 cm |
||
| 440 | _aAngiotensin converting enzyme inhibitation | ||
| 500 | _aProceedings of the A.N. Richards Symposium sponsored by the Physiological Society of Philadelphia, May 8-9, 1980 | ||
| 650 | 2 |
_aEnzyme Inhibitors _xcongresses |
|
| 650 | 2 |
_aAntihypertensive Agents _xcongresses |
|
| 650 | 2 |
_aPeptidyl-Dipeptidase A. _xantagonists & inhibitors _xcongresses |
|
| 650 | 2 |
_aProline _xcongresses |
|
| 700 | 1 | 0 | _aHorovitz, Zola P |
| 710 | 2 | 0 | _aPhysiological Society of Philadelphia |
| 942 |
_2ddc _cBK |
||